Rhinomed Limited [ASX:RNO] share price and news 2022

Company Description

Rhinomed Limited (RNO) is involved in research, development and commercialisation of consumer and medical devices. Rhinomed is an airway technology company that seeks to radically improve the way people breathe, sleep, maintain their health and take medication. Company finalised design and commenced production of two new products – Pronto Clear and Pronto Sleep. The new Pronto range delivers combined natural stenting of the nose with a proprietary formulation of natural essential oils.

Rhinomed Limited belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.rhinomed.global.

This a small cap company with market cap of 32 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 3.04 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how rno dividend grows in the recent years.

No data